Profound Medical Corp., receives CE Mark Approval for TULSA-PRO™
Apr 11, 2016 11:10 am UTC| Business
TORONTO, April 11, 2016 -- Profound Medical Corp. (“Profound” or “Company”) (TSXV:PRN), a medical device company commercializing a unique and minimally invasive therapy in prostate care, today announced that the company...
Baozun Releases 2015 Chairman Letter
Apr 11, 2016 11:06 am UTC| Business
SHANGHAI, China, April 11, 2016 -- Dear Shareholders: I would like to take this opportunity on behalf of everyone at Baozun to thank you all for your support over the past year. On May 21, 2015, we took Baozun...
Raptor Pharmaceutical Launches QUINSAIR™ in Europe
Apr 11, 2016 11:05 am UTC| Business
NOVATO, Calif., April 11, 2016 -- Raptor Pharmaceutical Corp. (Nasdaq:RPTP) today announced its first commercial sale of QUINSAIR™ (levofloxacin inhalation solution) in Germany and Denmark. QUINSAIR is approved in the...
GW Pharmaceuticals Initiates Phase 3 Pivotal Study in Tuberous Sclerosis Complex
Apr 11, 2016 11:00 am UTC| Business
LONDON, April 11, 2016 -- GW Pharmaceuticals plc (Nasdaq:GWPH) (AIM:GWP) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its...
SIPP International Industries, Inc. Announces Corporate Reorganization
Apr 11, 2016 11:00 am UTC| Business
TROY, Mich., April 11, 2016 -- SIPP International Industries, Inc. (OTC Markets:SIPN) announced today that it will enact sweeping administrative changes, including the relocation of the company's key personnel from Las...
DSP Group Inc.'s First Quarter 2016 Earnings Release and Conference Call
Apr 11, 2016 11:00 am UTC| Business
LOS ALTOS, Calif., April 11, 2016 -- DSP Group® Inc. (NASDAQ:DSPG), will release its earnings results for the first quarter of 2016 on April 27th, 2016 before market opens. The company would like to invite you to...
Apr 11, 2016 11:00 am UTC| Business
LEXINGTON, Mass., April 11, 2016 -- Curis, Inc. (NASDAQ:CRIS), a biotechnology company focused on the development and commercialization of innovative and effective drug candidates for the treatment of human cancers,...